Breaking News Instant updates and real-time market news.

PRNB

Principia Biopharma

$36.81

0.41 (1.13%)

16:05
03/19/19
03/19
16:05
03/19/19
16:05

Principia Biopharma reports Q4 EPS (37c), consensus (31c)

Reports Q revenue $26.1, may not compare to consensus $9.33M. In 2018, we made progress across all of our programs, in addition to completing a successful initial public offering. We continued the momentum into the new year with presentations at both the American Academy of Dermatology and the Americas Committee for Treatment and Research in Multiple Sclerosis," said Martin Babler, Chief Executive Officer of Principia. "In 2019, we are focusing on the continued clinical development of our assets. We will continue to expand enrollment in our Phase 3 program for PRN1008 around the world. One of our goals this year is to have top-line data from PRN1008 in both the Phase 2 clinical trial in immune thrombocytopenia and the Phase 2 extension trial in pemphigus."

PRNB Principia Biopharma
$36.81

0.41 (1.13%)

10/09/18
WELS
10/09/18
INITIATION
Target $45
WELS
Outperform
Principia Biopharma initiated with an Outperform at Wells Fargo
Wells Fargo analyst Jim Birchenough started Principia Biopharma with an Outperform rating and $45 price target. The analyst views the company's drug chemistry platform as "highly leveragable" and feels its lead product targeting BTK for autoimmune disease is differentiated.
10/09/18
LEER
10/09/18
INITIATION
Target $34
LEER
Outperform
Principia Biopharma initiated with an Outperform at Leerink
Leerink started Principia Biopharma with an Outperform rating and $34 price target.
10/09/18
LEER
10/09/18
INITIATION
Target $34
LEER
Outperform
Principia Biopharma initiated with an Outperform on sales forecast at Leerink
Leerink analyst Geoffrey Porges started Principia Biopharma with an Outperform rating and $34 price target. The analyst cited his sales forecast for lead asset PRN1008 in orphan diseases, pemphigus and immune thrombocytopenia purpura, which combined he believes can reach peak sales of about $550M risk-adjusted at 65% and 35% probability-of-success, respectively.
10/09/18
BARD
10/09/18
INITIATION
Target $50
BARD
Outperform
Principia Biopharma initiated with an Outperform at Baird
Baird analyst Brian Skorney started Principia Biopharma (PRNB) with an Outperform rating and $50 price target, stating that its BTK inhibitor partnered with Sanofi (SNY) for multiple sclerosis has blockbuster potential. He also believes PRN1008, which is entering Phase 3, has a worldwide opportunity over $500M in pemphigus that would also open the door for a host of other indications.

TODAY'S FREE FLY STORIES

WNS

WNS Holdings

$60.62

0.85 (1.42%)

06:04
10/17/19
10/17
06:04
10/17/19
06:04
Earnings
WNS Holdings sees FY20 adjusted EPS $2.93-$3.08, consensus $2.88 »

Sees FY20 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 22

    Oct

  • 11

    Nov

WNS

WNS Holdings

$60.62

0.85 (1.42%)

06:03
10/17/19
10/17
06:03
10/17/19
06:03
Earnings
WNS Holdings reports Q2 adjusted EPS 79c, consensus 67c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 22

    Oct

  • 11

    Nov

CMA

Comerica

$65.50

-1.505 (-2.25%)

06:02
10/17/19
10/17
06:02
10/17/19
06:02
Downgrade
Comerica rating change  »

Comerica downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FNB

F.N.B.

$12.02

0.09 (0.75%)

06:01
10/17/19
10/17
06:01
10/17/19
06:01
Earnings
F.N.B. reports Q3 EPS 31c, consensus 29c »

Reports Q3 book value per…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 13

    Nov

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$298.46

-0.44 (-0.15%)

05:58
10/17/19
10/17
05:58
10/17/19
05:58
General news
Boris Johnson announces 'great new' Brexit deal »

Prime Minister of the…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$298.46

-0.44 (-0.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$298.46

-0.44 (-0.15%)

05:55
10/17/19
10/17
05:55
10/17/19
05:55
General news
European Commission President says Brexit deal has been reached »

President of the European…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$298.46

-0.44 (-0.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WEGRY

Weir Group

$0.00

(0.00%)

05:51
10/17/19
10/17
05:51
10/17/19
05:51
Downgrade
Weir Group rating change  »

Weir Group downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPHHF

Sophos Group

$0.00

(0.00%)

05:50
10/17/19
10/17
05:50
10/17/19
05:50
Downgrade
Sophos Group rating change  »

Sophos Group downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ASOMY

Asos

$0.00

(0.00%)

05:49
10/17/19
10/17
05:49
10/17/19
05:49
Upgrade
Asos rating change  »

Asos upgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 22

    Oct

BC

Brunswick

$55.47

0.46 (0.84%)

05:48
10/17/19
10/17
05:48
10/17/19
05:48
Downgrade
Brunswick rating change  »

Brunswick downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

BBT

BB&T

$53.00

0.25 (0.47%)

05:47
10/17/19
10/17
05:47
10/17/19
05:47
Earnings
BB&T reports Q3 adj. EPS $1.07, consensus $1.03 »

Reports Q3 revenue $3B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 08

    Nov

ASML

ASML

$254.52

-13.04 (-4.87%)

05:45
10/17/19
10/17
05:45
10/17/19
05:45
Downgrade
ASML rating change  »

ASML downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

PFBC

Preferred Bank

05:43
10/17/19
10/17
05:43
10/17/19
05:43
Downgrade
Preferred Bank rating change  »

Preferred Bank downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

SAM

Boston Beer

$382.92

-4.92 (-1.27%)

05:41
10/17/19
10/17
05:41
10/17/19
05:41
Upgrade
Boston Beer rating change  »

Boston Beer upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

SBNY

Signature Bank

$118.68

-0.1 (-0.08%)

05:41
10/17/19
10/17
05:41
10/17/19
05:41
Earnings
Signature Bank reports Q3 EPS $2.75, consensus $2.70 »

Reports Q3 book value per…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 29

    Oct

NGG

National Grid

$57.08

0.305 (0.54%)

05:34
10/17/19
10/17
05:34
10/17/19
05:34
Upgrade
National Grid rating change  »

National Grid upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TGVSF

Tryg

$0.00

(0.00%)

05:33
10/17/19
10/17
05:33
10/17/19
05:33
Upgrade
Tryg rating change  »

Tryg upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LILA

Liberty Latin America

$18.14

0.14 (0.78%)

05:31
10/17/19
10/17
05:31
10/17/19
05:31
Upgrade
Liberty Latin America rating change  »

Liberty Latin America…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRUS

Cirrus Logic

$54.53

-0.79 (-1.43%)

05:31
10/17/19
10/17
05:31
10/17/19
05:31
Upgrade
Cirrus Logic rating change  »

Cirrus Logic upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

  • 13

    Nov

XHR

Xenia Hotels

05:27
10/17/19
10/17
05:27
10/17/19
05:27
Downgrade
Xenia Hotels rating change  »

Xenia Hotels downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

CYOU

Changyou.com

$9.44

0.12 (1.29%)

, SOHU

Sohu.com

$10.22

-0.16 (-1.54%)

05:26
10/17/19
10/17
05:26
10/17/19
05:26
Hot Stocks
Changyou.com forms independent special committee to review acquisition proposal »

Changyou.com (CYOU)…

CYOU

Changyou.com

$9.44

0.12 (1.29%)

SOHU

Sohu.com

$10.22

-0.16 (-1.54%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VRNA

Verona Pharma

$4.07

(0.00%)

05:24
10/17/19
10/17
05:24
10/17/19
05:24
Hot Stocks
Verona completes enrollment in nebulized ensifentrine Phase 2b clinical trial »

Verona Pharma announces…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ERIC

Ericsson

$8.63

0.175 (2.07%)

05:22
10/17/19
10/17
05:22
10/17/19
05:22
Earnings
Ericsson reports Q3 EPS (SEK 1.89) vs. SEK 0.83 »

Reports Q3 revenue SEK…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 17

    Oct

NFLX

Netflix

05:18
10/17/19
10/17
05:18
10/17/19
05:18
Recommendations
Netflix analyst commentary  »

Piper reiterates…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

NFLX

Netflix

$286.83

2.59 (0.91%)

05:13
10/17/19
10/17
05:13
10/17/19
05:13
Downgrade
Netflix rating change  »

Netflix downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.